DiscoverCCO Medical Specialties PodcastEvidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease
Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

Update: 2025-06-24
Share

Description

In this episode, Andrew F. Alexis, MD, MPH, and Daniel C. Butler, MD, discuss the immunopathogenesis and role of IL-13 in atopic dermatitis (AD), including:

  • Contributors to epidermal barrier dysfunction (eg, environmental triggers)
  • IL-13 as a key cytokine in AD pathogenesis
  • Targeted AD therapies that inhibit IL-13
  • A detailed patient case to highlight take-home points

Presenter

Andrew F. Alexis, MD, MPH​
Professor of Clinical Dermatology​
Weill Cornell Medical College ​
New York, New York

Daniel C. Butler, MD​
Assistant Dean Student Affairs​
University of Arizona College of Medicine – Tucson​
Tucson, Arizona

Program page: 
https://bit.ly/4kTP04D

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

Evidence-Based Care in Atopic Dermatitis: Mapping IL-13 to the Clinical Manifestations of Moderate to Severe Disease

Andrew F. Alexis MD MPH, Daniel C. Butler MD